000 | 01595 a2200469 4500 | ||
---|---|---|---|
005 | 20250515151752.0 | ||
264 | 0 | _c20090105 | |
008 | 200901s 0 0 eng d | ||
022 | _a1365-3024 | ||
024 | 7 |
_a10.1111/j.1365-3024.2008.01063.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSaldanha, J C S | |
245 | 0 | 0 |
_aChronic antigen ingestion protects ovalbumin sensitized mice from severe manifestation of Leishmania major infection. _h[electronic resource] |
260 |
_bParasite immunology _c |
||
300 |
_a646-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Protozoan _xblood |
650 | 0 | 4 |
_aFoot _xparasitology |
650 | 0 | 4 | _aImmunization |
650 | 0 | 4 |
_aImmunoglobulin E _xblood |
650 | 0 | 4 |
_aImmunoglobulin G _xblood |
650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
650 | 0 | 4 |
_aLeishmaniasis, Cutaneous _ximmunology |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aOvalbumin _xadministration & dosage |
650 | 0 | 4 |
_aSpleen _ximmunology |
700 | 1 | _aGargiulo, D L | |
700 | 1 | _aDourado, L P A | |
700 | 1 | _aSantiago, H C | |
700 | 1 | _aMenezes, G B | |
700 | 1 | _aReis, M L C | |
700 | 1 | _aTafuri, W L | |
700 | 1 | _aTeixeira, M M | |
700 | 1 | _aVieira, L Q | |
700 | 1 | _aCara, D C | |
773 | 0 |
_tParasite immunology _gvol. 30 _gno. 11-12 _gp. 646-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-3024.2008.01063.x _zAvailable from publisher's website |
999 |
_c18520892 _d18520892 |